WNS or TRI: Which Is the Better Value Stock Right Now?

Zacks analysis identifies WNS (Holdings) Limited (WNS) as a superior value stock compared to Thomson Reuters (TRI) within the Business - Services sector. WNS holds a Zacks Rank of #2 (Buy) versus TRI's #3 (Hold), indicating a stronger earnings outlook for WNS. Valuation metrics further support this, with WNS exhibiting significantly lower forward P/E (16.27 vs. 51.03), PEG ratio (1.79 vs. 6.17), and P/B ratio (4.12 vs. 7.34), leading to a Zacks Value grade of 'B' for WNS against 'F' for TRI.

Analysis

A comparative analysis between WNS (Holdings) Limited and Thomson Reuters within the Business - Services sector indicates a stronger value proposition for WNS. WNS currently holds a Zacks Rank of #2 (Buy), suggesting a more positive trend in earnings estimate revisions compared to TRI's #3 (Hold) rank. This superior earnings outlook is complemented by a significant valuation discount across several key metrics. WNS trades at a forward P/E ratio of 16.27, substantially lower than TRI's 51.03. Furthermore, its PEG ratio of 1.79 is more attractive than TRI's 6.17, indicating a more reasonable price relative to its expected earnings growth. The disparity is also evident in the price-to-book ratio, where WNS stands at 4.12 versus 7.34 for TRI. These quantitative factors culminate in WNS earning a 'B' grade for Value in the Zacks Style Scores system, while TRI receives an 'F', reinforcing the assessment that WNS is the superior value opportunity at present.

Key Decisions for Investors

• Value-oriented investors seeking exposure to the Business - Services sector should consider WNS, as its favorable earnings outlook and significantly lower valuation multiples present a more compelling case compared to Thomson Reuters.
• Investors holding Thomson Reuters may want to reassess their position, given its high valuation demonstrated by a forward P/E of 51.03 and a PEG ratio of 6.17, which contribute to its 'F' grade for value.
• A key catalyst to monitor for WNS is the continuation of positive earnings estimate revisions, which underpins its current #2 (Buy) Zacks Rank and the core of the value thesis.